Speaker illustration

Doctor Georg Marcus Froehlich

Charite University Hospital, Berlin (Germany)

Randomized clinical trial comparing a rivaroxaban-based with an antiplatelet-based strategy for cerebral embolization after TAVR (EARTH TAVR)-a magnetic resonance imaging substudy of the GALILEO trial

Event: ESC Congress 2020

Topic: Aortic Valve Intervention

Session: Optimizing Risk Stratification and Technical Aspects of TAVI Procedures

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb